Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01643616
Other study ID # HV 2010 003
Secondary ID
Status Completed
Phase N/A
First received July 16, 2012
Last updated August 27, 2013
Start date November 2010
Est. completion date September 2012

Study information

Verified date August 2013
Source Helios Research Center
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Interventional

Clinical Trial Summary

For distal sciatic nerve block this prospective, randomised comparison with ultrasound guided distal subepineural block tested the hypothesis, that intraepineural injection of local anesthetic using nerve stimulation technique is common and associated with high success rate.


Description:

Classical methods for nerve localization (loss of resistance, cause of paresthesias, nerve stimulation technique)assumed that the target is a close approximation to the nerve, without epineural perforation. Intraneural injections were considered as evitable, with high risk for nerve damages.

Ultrasound guidance provided for the first time a real-time visualization of the spread of local anesthetic. Some recent studies proved, that an intraneural injection using nerve stimulator technique is common and not necessarily accompanied with nerve damages.

In the ultrasound group (group US) the investigators tested the hypothesis, that an intraneural injection of local anesthetic generate a high success rate and a short onset time without clinical apparent nerve damages.

In the nerve-stimulation group (group NS) the investigators tested the hypothesis, that an intraneural injection of local anesthetic is common, and in case of intraneural injection accompanied likewise with high success rate and shorter onset time.

For the sciatic division the investigators tested the hypothesis, that classical methods of nerve localization (nerve-stimulation technique, cause of paresthesias) are not able to avoid epineural perforation.


Recruitment information / eligibility

Status Completed
Enrollment 250
Est. completion date September 2012
Est. primary completion date June 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- elective surgery on the foot or ankle

- tourniquet distal of the knee

- adult patients, 18-75 years old

- ASA-risk-groups I-III (American Society of Anesthesiologists)

- informed consent

Exclusion Criteria:

- severe coagulopathy

- systemic inflammatory response

- ASA-risk-groups > III (American Society of Anesthesiologists)

- drug allergy: local anesthetics

- pregnancy, lactation period

- participation in other studies

- addiction to drugs or alcohol

- non-cooperative patients

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
midazolam
Prior to performing the regional anesthesia the investigators administered midazolam as a premedication by mouth (3,75-7,5mg) or intravenously (2-3mg).
Prilocaine 1%
20ml Prilocaine 1% for distal sciatic nerve block (30ml Prilocaine 1% in outpatients)
Ropivacaine 0.75%
10ml Ropivacaine 0.75% for distal sciatic nerve block (not in outpatients)
Prilocaine 1%
10ml Prilocaine 1% for saphenous nerve block
Device:
ultrasound guidance
In group US the sciatic nerve localization and needle guidance is realized using ultrasound.
nerve stimulation technique
In the group NS sciatic nerve localization and needle guidance is realized using nerve stimulation technique. However, ultrasound is used observing (Observer) the procedure, but blinded for the physician (Anesthetist) performing the block.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Helios Research Center

Outcome

Type Measure Description Time frame Safety issue
Primary Success Rate Without Supplementation After injection of local anesthetic a waiting period of 30-60 minutes was defined before completing a failed block.
success without supplementation = no additional analgetics or rescue blocks required (success rate without supplementation, outcome measure 1)
success with supplementation = analgetics or selective rescue blocks distal of the sciatic division required (success rate without supplementation and additionally all supplemented blocks, outcome measure 3)
failed block = change of anesthetic procedure (general, spinal) or rescue blocks proximal of the sciatic division
within 30-60 minutes after injection of the local anesthetic No
Primary Time Until Readiness for Surgery (Minutes) within 60 minutes after injection of the local anesthetic No
Primary Success Rate With Supplementation After injection of local anesthetic a waiting period of 30-60 minutes was defined before completing a failed block.
success without supplementation = no additional analgetics or rescue blocks required (success rate without supplementation, outcome measure 1)
success with supplementation = analgetics or selective rescue blocks distal of the sciatic division required (success rate without supplementation and additionally all supplemented blocks, outcome measure 3)
failed block = change of anesthetic procedure (general, spinal) or rescue blocks proximal of the sciatic divisionSucces rate with supplementation
later than 30-60 minutes after injection of the local anesthetic No
See also
  Status Clinical Trial Phase
Completed NCT02429414 - Video Double-Lumen Tube Prospective Randomized Study Phase 3
Completed NCT02516566 - Effects of PEEP on Optic Nerve Sheath Diameter During Robot-Assisted Laparoscopic Prostatectomy N/A
Completed NCT02248688 - Gastric Artery Embolization Trial for Lessening Appetite Nonsurgically N/A
Completed NCT01309360 - Ultrasound-guided Axillary Plexus Block - Dose Reduction of Prilocaine Phase 4
Completed NCT01433029 - Objective Assessment of Technical Skills in Cardiothoracic Surgery N/A
Completed NCT02494856 - Comparison of the Clinical Efficacy of Naproxen, Associated or Not With Esomeprazol, in Lower Third Molar Removal Phase 4
Completed NCT02263443 - Appropriated Bowel Preparation Before Exploratory Laparotomy in Gynecologic Surgery N/A
Completed NCT02450487 - Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery Phase 4
Completed NCT01726231 - Evaluation of Abdominal Wall Lifting During Laparoscopic Direct Trocar Insertion N/A
Completed NCT02906969 - Colonoscopy Educational Video Upon Inner City Population N/A
Completed NCT01580176 - Continuous GlucoseMonitor for Measurement of Blood Glucose Level N/A
Completed NCT02730026 - Comparison of the Clinical Efficacy of Ketoprofen, Associated or Not With Omeprazole in Lower Third Molar Removal Phase 4
Active, not recruiting NCT02525406 - Models for Improving Operating Room Productivity: Delays, Cancellations and Pre-admission Testing
Recruiting NCT01491165 - Safety and Efficacy of Stem Cell Transplantation for Treatment of Liver Cirrhosis Phase 2/Phase 3
Active, not recruiting NCT03169127 - Clinical Pharmacogenetic of Ibuprofen After Lower Third Molar Surgeries Phase 4